Novel therapies for resistant focal segmental glomerulosclerosis (FONT) phase II clinical trial: study design

BACKGROUND: The lack of adequate randomized clinical trials (RCT) has hindered identification of new therapies that are safe and effective for patients with primary focal segmental glomerulosclerosis (FSGS), especially in patients who fail to respond to corticosteroids and immunosuppressive therapie...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Trachtman, Howard, Vento, Suzanne, Gipson, Debbie, Wickman, Larysa, Gassman, Jennifer, Joy, Melanie, Savin, Virginia, Somers, Michael, Pinsk, Maury, Greene, Tom
Format: Artigo
Sprache:Inglês
Veröffentlicht: BioMed Central 2011
Schlagworte:
Study Protocol
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3045306/
https://ncbi.nlm.nih.gov/pubmed/21310077
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2369-12-8
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge